Dai­ichi Sankyo says pro­duc­tion boost in US will help cush­ion tar­iff im­pact

Dai­ichi Sankyo has re­it­er­at­ed that its ear­li­er plans to ex­pand ADC man­u­fac­tur­ing in the US, in­clud­ing for its block­buster drug En­her­tu, will help al­le­vi­ate some …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER